Company / Working Capital
ResMed Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$2.5B
FY2025
5-year range
$663.0M / $2.5B
FY2021-FY2025
Trend
+71.8%
vs FY2024
Sector context
#19 of 165
Health Care
What the data says
ResMed's working capital of $2.5B is higher than 88% of companies in the Health Care sector (FY2025). Working Capital has fluctuated over the past 10 years, ranging from $554M in FY2018 to $2.5B in FY2025.
Based on SEC 10-K filings.
$2.5B in FY2025 with a 5-year CAGR of +22.0%. Top quartile in the Health Care sector.
Improved from $1.6B to $2.5B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +26.0%
- 5-Year CAGR
- +22.0%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 165This company $2.5B Sector average $814.4M
▼
+205.3% above sector average
Key checks
Key Insights
- 5-year CAGR of +22.0%, indicating consistent growth.
- In FY2025, working capital increased 71.8% year-over-year.
- Ranks #19 out of 165 companies in the Health Care sector.
- Lowest working capital in the period was in FY2018.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.5B | +71.8% |
| FY2024 | $1.4B | -10.1% |
| FY2023 | $1.6B | +29.6% |
| FY2022 | $1.2B | +87.4% |
| FY2021 | $663.0M | -28.0% |
| FY2020 | $920.7M | +56.2% |
| FY2019 | $589.4M | +6.3% |
| FY2018 | $554.5M | -56.8% |
| FY2017 | $1.3B | +64.2% |
| FY2016 | $781.7M | -31.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026